Due to a national shortage of blood collection tubes, you may experience upwards of a 2-hour delay in processing time for certain tests. Someone from our team will advise you if your scheduled lab test is affected by this delay. We thank you in advance for your patience.

Clinical Trials & Research

Ph3 FGFR erdafitinib urothelial

(42756493BLC3001) A Phase 3 Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations (THOR)

Disease Types: Bladder,&nbs

Available at: {clinical_trial_location backspace="7"}Ph3 FGFR erdafitinib urothelial, {/clinical_trial_location}

Principal Investigator: {clinical_trial_principle_investi} , {/clinical_trial_principle_investi}

{clinical_trial_description}